BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18592095)

  • 21. Interaction between nitric oxide and renal α1-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats.
    Ahmad A; Sattar MA; Azam M; Khan SA; Bhatt O; Johns EJ
    PLoS One; 2018; 13(2):e0189386. PubMed ID: 29447158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts.
    Nadruz W; Lagosta VJ; Moreno H; Coelho OR; Franchini KG
    Hypertension; 2004 May; 43(5):1060-6. PubMed ID: 15023931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein prevents myocardial hypertrophy in 2-kidney 1-clip renal hypertensive rats by restoring eNOS pathway.
    Li J; Xie ZZ; Tang YB
    Pharmacology; 2010; 86(4):240-8. PubMed ID: 20938214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy.
    Kamezaki F; Tsutsui M; Takahashi M; Sonoda S; Kubo T; Fujino Y; Adachi T; Abe H; Takeuchi M; Mayumi T; Otsuji Y
    Hypertension; 2014 Sep; 64(3):516-22. PubMed ID: 24914203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High salt intake accelerated cardiac remodeling in spontaneously hypertensive rats: time window of left ventricular functional transition and its relation to salt-loading doses.
    Gao F; Han ZQ; Zhou X; Shi R; Dong Y; Jiang TM; Li YM
    Clin Exp Hypertens; 2011; 33(7):492-9. PubMed ID: 21529316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
    Quintana-Villamandos B; Delgado-Baeza E
    Med Hypotheses; 2016 Feb; 87():44-7. PubMed ID: 26826640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertrophy of the heart: a new therapeutic target?
    Frey N; Katus HA; Olson EN; Hill JA
    Circulation; 2004 Apr; 109(13):1580-9. PubMed ID: 15066961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
    Li YS; Wang ZH; Yan L; Yong YQ; Wang J; Liang QS; Zheng Z; Yang GT
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
    Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
    Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
    Pechánová O; Bernátová I; Pelouch V; Simko F
    J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.
    Liang WY; Liu WW; Liu ML; Xiang W; Feng XR; Huang B; Chen XH; Sun YS
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):575-580. PubMed ID: 27162100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse electrical remodeling following pressure unloading in a rat model of hypertension-induced left ventricular myocardial hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Merkely B; Karck M; Radovits T; Szabó G
    Hypertens Res; 2017 Jul; 40(7):637-645. PubMed ID: 28123181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
    Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
    Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INCREASED OXIDATIVE STRESS AND DOWN REGULATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) IN THE KIDNEY ATTEN- UATE THE RESPONSIVENESS OF (XlB ADRENERGIC RECEPTORS IN THE KIDNEY OF RATS WITH LEFT VENTRICULAR HYPERTROPHY.
    Ahmad A; Sattar M; Khan SA; Abdullah NA; Johns EJ; Afzal S
    Acta Pol Pharm; 2017 Mar; 74(2):413-423. PubMed ID: 29624247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.
    Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH
    Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of left ventricular hypertrophy and implications for regression.
    Artham SM; Lavie CJ; Milani RV; Patel DA; Verma A; Ventura HO
    Prog Cardiovasc Dis; 2009; 52(2):153-67. PubMed ID: 19732607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide and cardiac remodeling.
    Passeri J; Bloch KD
    Heart Fail Clin; 2005 Jul; 1(2):275-86. PubMed ID: 17386852
    [No Abstract]   [Full Text] [Related]  

  • 39. Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart.
    Prabhu SD
    Circ Res; 2004 May; 94(9):1155-7. PubMed ID: 15142968
    [No Abstract]   [Full Text] [Related]  

  • 40. Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease.
    Frohlich ED
    Braz J Med Biol Res; 2000 Jun; 33(6):693-700. PubMed ID: 10829097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.